Background/Aims: To evaluate the occurrence of gastroesophageal reflux and possible mechanisms in Helicobacter pylori infection. Materials and Methods: Symptoms of H. pylori-infected children, their total gastroesophageal reflux episodes, acid exposure percentage, gastrin, ghrelin, and motilin levels were evaluated before and after H. pylori eradication. Results: Forty-two H. pylori-infected children were eligible for this study. Acid exposure % and total reflux episodes before and after H. pylori eradication were 10.2%±14.8% vs. 7.71%±5.0% and 94.7%±102.1% vs. 64.6%±55.0%, respectively (p=0.28, p=0.082). There was an insignificant change in the serum gastrin (93.4±153.8 pmol/L vs. 1.28±149.4 pmol/L, p=0.67), ghrelin (7.69±197.5 pg/mL vs. 8.36±299.5 pg/mL, p=0.274), and motilin (75.1±81.2 pg/mL vs. 97.2±80.5 pg/mL, p=0.206) levels after eradication. Gastrin and ghrelin levels were negatively correlated after H. pylori eradication (r=−0.38, p=0.031). There was no association between gastroesophageal reflux episodes and gastrin, ghrelin, and motilin levels (r=0.25 and p=0.11; r= 0.24 and p=0.13; r=-0.23 and p=0.14, respectively) Conclusion: H. pylori infection is neither protective nor harmful in the gastroesophageal reflux. Neither ghrelin nor motilin levels was associated with gastroesophageal reflux. None of gastrin, ghrelin, and motilin levels was affected by H. pylori infection. There is an inverse association between gastrin and ghrelin levels after H. pylori eradication.
INTRODUCTION
Gastroesophageal reflux disease (GERD) is a multifactorial, acid-peptic disorder that results from the reflux of gastric content into the esophagus. The main proposed mechanism in its development is the increased intermittent relaxation of the lower esophageal sphincter (LES). However, various host-related and environmental factors interfering with an intact competent esophagogastric junction and normal esophageal acid clearance may also contribute to GERD development.
The possible role of H. pylori infection in GERD has recently become a topic of major interest. Some studies have suggested a protective role of H. pylori and exacerbation of GERD after eradication (1) , although other authors did not confirm this. These controversial results used to be explained with the anatomic location of H. pylori infection and the consequent hypo or hyper acidity. Within the context of these hypotheses, gastrin, which is the main regulatory hormone in acid secretion, gains importance (2, 3) .
H. pylori infection may lead to changes on various motility-regulating gastric hormones such as ghrelin and motilin (4) (5) (6) . Motilin, an endogenous prokinetic hormone, is secreted by gastrointestinal endocrine cells. Besides initiating gastric contraction that distally propagates in the gastrointestinal tract, motilin increases LES pressure acting both via the enteric nervous system and directly on the LES muscle (7) . To the best of our knowledge, only a few studies evaluated the effect of H. pylori infection on motilin secretion.
Another peptide that is influenced by H. pylori infection is ghrelin. It is an appetite-increasing peptide that is structurally related to motilin and is produced by the enteroendocrine cells of gastric mucosa (5) . It stimulates gastric acid secretion, gastrointestinal motility, gastric emptying via the vagus nerve, and histamine release (8) . The effect of H. pylori infection on ghrelin concentration has been evaluated in a few studies (5 In this study, our primary aim was to evaluate the possible causal relationship between H. pylori infection and GERD occurrence in children. Gastrin level was measured to define the relationship between the H. pylori infection region and GERD occurrence. Because GERD is primarily a motility-related disorder, the secondary aim of our study was to evaluate the effect of H. pylori infection on prokinetic hormones, such as ghrelin and motilin, that may account for the occurrence of GERD in children.
MATERIALS AND METHODS
This prospective cohort study was conducted with children who presented with abdominal pain and dyspeptic symptoms to the Eskişehir Osmangazi University, Department of Pediatric Gastroenterology and Hepatology. Patients with chronic gastrointestinal disease and neurological sequela, celiac disease, cirrhosis, eosinophilic esophagitis, cerebral palsy, and those who received any prokinetics (metoclopropamid, domperidon, erythromycin, and rifaxamin), antibiotics, antacids, and acid blockers 1 month prior to recruitment were excluded from the study. Children who underwent upper gastrointestinal system endoscopy (Olympus XQ260N, Tokyo, Japan) and those with documented H. pylori infection (n=42) were prospectively recruited for measurements of gastrin, ghrelin, and motilin levels and 24-h ambulatory multichannel intraluminal impedance pH monitorization (MII-pH) before and after H. pylori eradication (as soon as eradication was demonstrated, in the same week). H. pylori infection was diagnosed with a positive urease test and/ or histology. Esophagitis, if detected at endoscopy, was graded according to the Savary-Miller classification (9) . At least six biopsies, three each from antrum and corpus, were obtained during endoscopy. Two of these biopsies were sent for histological examination and the remaining two (one from antrum and one from corpus) were used for the urease test. Biopsies were assessed according to the updated Sydney system (10) . For H. pylori eradication, patients received a first-line regimen of triple therapy comprising lansoprozole (1-1.4 mg/kg/day), amoxicillin (30 mg/kg/day), and clarithromycin (15 mg/kg/ day) for a two-week period. Those who did not achieve H. pylori eradication underwent a second-line regimen comprising lansoprozole (1-1.4 mg/kg for 14 days), metronidazole (30 mg/kg for 7 days), doxycycline (2 mg/ kg/day for 7 days), and bismuth subcitrate (8 mg/kg/day for 7 days). Patients in whom the firstand second-line therapy had failed to eradicate H. pylori infection were administered a third-line rescue treatment comprising lansoprozole (1-1.4 mg/kg/day), levofloxacin (10 mg/kg/ day twice daily), and metronidazole (30 mg/kg/day three times a day). Eradication was examined via C14 urea breath test, 6 weeks after the termination of the eradication protocol (11).
Impedance pH monitorization was performed with an ambulatory MII-pH system (Ohmega, MMS, USA) using a pH tip TM disposable catheter (Unisensor AG, Switzerland). Storbel's formula [(0.252xbody length/height cm)+5] was used to estimate the appropriate probe location. Catheter was transnasally inserted, advanced until the pH dropped below 4, and then pulled back to the estimated length. The accuracy of the catheter level was checked with a chest X-ray. If required, adjustment was done so that the first electrode was positioned two vertebras above the diaphragm at the level of the vertebral column. Impedance values were recorded at six points. Acid exposure time % and total reflux episodes were compared before and after H. pylori eradication. Esophageal acid exposure time % of >4 was accepted as significant gastroesophageal reflux.
Serum gastrin (n=41), motilin (n=42) measurements were performed with commercially available ELISA kits (Diasource Immunoassay S.A., Belgium for gastrin and Cusabio Biotech Ca., Ltd., Hubie, China for motilin) after overnight fasting. Similarly, ghrelin (n=42) level was measured in the morning after overnight fasting before meal but with the RIA kit (Millipolar, Missouri, USA). The study was approved by the institutional ethics committee, and all parents provided written and verbal informed consent for each of these procedures.
Statistical analysis was performed with the software of SPSS 16.0 for windows (IMB corp., NY, USA). Normality for quantitative variables was checked with the Kolmogorov-Smirnov test. None of the nominal variables were normally distributed. Data were presented as the arithmetic mean±standard deviation. Mean of the normally distributed variables were compared with the Student's t-test and 95% confidence dense intervals were provided. Mean of non-normally distributed variables were evaluated with Wilcoxon sign test. For categorical variables, frequencies and percentages were determined, and variables were compared with the McNemar test. For correlation analysis, Spearman correlation tests (for ghrelin, motilin, and gastrin) was used. P value <0.05 was considered statistically significant. Table 2 . None of them had atrophy or intestinal metaplasia.
RESULTS
At diagnosis, 27 (64.2 %) patients had GERD. Although the number of patient with GERD increased after H. pylori eradication (p=0.44), there was no difference in pre-/post-eradication acid exposure % and total reflux episodes ( Regarding the effect of H. pylori infection on serum gastrin, ghrelin, and motilin levels, after eradication we observed a decrease in gastrin level and an increase in both the ghrelin and motilin levels. However, none of these changes were statistically significant (Table 3 ).
There was no correlation between the gastroesophageal reflux episodes and gastrin, ghrelin, and motilin levels (r=0.25 and p=0.11; r=0.24 and p=0.13; r=−0.23 and p=0.14, respectively).
Concerning gastrin and ghrelin association, we detected a negative correlation after H. pylori eradication (r=−0.38, p=0.031).
DISCUSSION
Although the prevalence of H. pylori infection is not different between patients with GERD and healthy subjects, a significant proportion of patients with GERD also have H. pylori infection (12, 13 (Table 2 ). Except regurgitation symptoms that are most likely associated to gastroesophageal reflux, such as retrosternal pain, belching, and heartburn, did not demonstrate any improvement or worsening.
Most of the studies evaluating the association of GERD and H. pylori infection have been conducted with adult patients. In these studies, the proposed primary mechanism by which H. pylori influences the pathogenesis of GERD depends on the modification of gastrin and gastric acid secretion. Gastrin is released by antral G cells, and it is often increased in H. pylori-infected adults (16, 17) . Depending on the anatomical region and the consequence of infection, the serum level of gastrin and its effect may vary. According to the current proposed mechanism, the protective effect is mediated by H. pylori-induced corpus-limited gastritis, which results in hypoacidity as a consequence of parietal cell destruction. This resulting hypoacidity leads to increased gastrin release that ends up with rebound hyperacidity and GERD development after eradication. On the contrary, in antrum-limited H. pylori infection, because of the destruction of somatostatinsecreting cells, an unopposed hypergastrinemia occurs during infection. Consequently, acid secretion increases from the intact corpal parietal cells, resulting in increased occurrence of GERD in the H. pylori-infected state. However, if the nature of gastritis is atrophic, then the opposite occurs. Gastrin level decreases because of the antral G cell atrophy, and the resulting hypoacidity provides protects from GERD development (2, 3) . In our study, we observed neither a change in the gastrin level nor in GERD occurrence between H. pylori-infected and non-infected state. In contrast to these hypotheses, we could not demonstrate any relationship between gastrin and GERD, which was comparable with a few studies in the literature (18) (19) (20) (21) (22) (23) (24) . One of the reasons for this difference can be the predominant corpoantral infection in our patients. It appears that the hypoacidic state of corpus gastritis was opposed by the hyperacidic antral gastritis. Another reason can be the nature of the infection that H. pylori causes in children. Atrophic gastritis, which may be encounter to the hypogastrinemia and hypoacidity in adults, is rare in children (25) . In a study, atrophic gastritis was detected only in 6% of the children. Gastric atrophy has been reported to exert an 80% decrease in GERD symptoms, and a decrease in gastrin level has been proposed as a predictor of atrophic gastritis. None of our patients had atrophic gastritis, and gastrin level did not change between pre-and post-eradication state. May be because of this, most of our patients had GERD even though they were infected with H. pylori, and we could not observe any change in GERD occurrence after eradication.
Because GERD is mainly a motility-related disorder, we also focused on esophageal motility-related hormones. Wu et al. (12) studied the effect of H. pylori infection on gastric motility in patients with non-erosive GERD. They could not demonstrate any significant difference in the esophageal sphincter pressure or esophageal peristaltic function between H. pylori-positive and -negative controls. However, they demonstrated that H. pyloriinfected patients with reflux esophagitis have higher prevalence of esophageal motor abnormalities. Therefore, a concomitant esophageal motility abnormality appears likely rather than just the type or localization of gastritis. In this context, we studied the association of H. pylori infection and prokinetic hormones, ghrelin, and motilin. In the beginning, we hypothesized that H. pylori infection alters these prokinetic hormones; thus, infected patients will have impaired esophageal acid clearance and gastric emptying, contributing to GERD development. We realized that little is known regarding the effect of H. pylori infection on motilin secretion. To the best of our knowledge, only adult studies evaluated this association (6). Although we have found lower levels with infection, the difference between the infective and non-infective phase was insignificant. This finding was consistent with the study of Dominguez-Munoz et al. (6) that was conducted in adult patients. We could not determine any correlation between reflux episodes and motilin levels as well.
Animal studies revealed association between ghrelin and gastric emptying (2, 26) . With similar action as motilin, it has been proposed that the increase in ghrelin level can affect LES pressure and decrease GERD (27) . Ghrelin was found to be decreased in both the plasma and gastric cell in H. pylori infection and to be increased after eradication (5, (28) (29) (30) . It has been reported that the decrease of ghrelin abolishes the control on LES and increases GERD development (27) . However, we could not observe any significant increase in ghrelin level after eradication.
To date, two theories were proposed regarding the mechanism by which H. pylori infection leads to reduction in the plasma In conclusion, our findings suggest that H. pylori infection is unlikely to have a major effect on GERD occurrence and the relevant prokinetic hormones that affect the esophageal motor function. There is an inverse relationship between gastrin and ghrelin levels. The former decreases as the latter increases. However, even this does not have any effect on GERD occurrence.
This is the first study that evaluates the effect of H. pylori infection on motilin secretion in children. However, our study had certain limitations. First; it was an open-label, longitudinal study, and we did not have a control group. Although the time interval was long enough to avoid bias after eradication, this study still provided information regarding what happens in a previously H. pylori-infected child after eradication rather than the difference between an infected and non-infected child. However, these study types have certain advantages that cannot be ignored. Each subject acts as his/her own control. Despite this, additional motility and manometric studies would be helpful for further investigation that focused on the relation between H. pylori infection, gastroesophageal motility, and prokinetic hormone and gastroesophageal motility.
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